| PGR |
Report |
Q2 GAAP EPS |
BEAT |
pred ~$5.67 vs. cons $4.73 |
HIGH |
| PGR |
Report |
Q2 companywide combined ratio |
BEAT |
pred ~87.3% vs. cons 88.4% |
HIGH |
| PGR |
Report |
Q2 net premiums earned |
IN-LINE |
pred ~$21.57B vs. cons $21.60B |
HIGH |
| PGR |
Guide |
Companywide net-premium-written growth |
LOWER |
guide ~5.5% vs. cons 6.0% (FY2026) |
MEDIUM |
| PGR |
Guide |
Companywide policies-in-force growth |
LOWER |
guide ~6.5% vs. cons 7.0% (FY2026) |
MEDIUM |
| PGR |
Guide |
Companywide underwriting margin |
LOWER |
guide ~8.5% vs. cons 9.5% (H2 2026) |
MEDIUM |
| PGR |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| PGR |
Return |
5-day cumulative residual |
-2.8% (FOLLOW-THROUGH) |
Lower growth and margin assumptions imply FY2026 EPS revisions of approximately -3% versus roughly 0% before the call; those out-period cuts should outweigh the already-reported Q2 EPS beat and drive modest negative follow-through. |
MEDIUM |